STAT3 and colonic neoplasm: Treatment of Apcmin/+ mice with the STAT3 inhibitor BP-1-102 [50] reduced the growth of colonic tumours via the downregulation of STAT3 activity and STAT3-dependent NF-κβ activation [51].